Stock PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Real-time Estimate Cboe BZX
Other stock markets
 15:13:07 29/04/2024 BST 		5-day change 1st Jan Change
1.555 USD +5.78% Intraday chart for Pacific Biosciences of California, Inc. +1.32% -83.89%
04-22 JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight MT
04-18 Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue
Pacific Biosciences of California, Inc. Announces Resignation of David Botstein from the Board
Pacific Biosciences of California Shares Rise After UBS Upgrade
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
Pacific Biosciences of California Teams Up With Geneyx, Golden Helix in Disease Research
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
Pacific Biosciences of California Q3 Loss Narrows, Revenue Gains
Pacific Biosciences of California, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Pacific Biosciences of California, Inc. Appoints David Meline to Audit Committee
Pacific Biosciences of California, Inc. Appoints David Meline to its Board of Directors
Pacbio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
Children's Mercy Kansas City First to Use 5-Base HiFi Sequencing from PacBio
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. News Pacific Biosciences of California, Inc.
  5. Other languages